Category:
Active Pharmaceutical Ingredients
CAS NO:
1009119-64-5
Standard:
In-house Standards,
Hepatitis C
Daclatasvir (BMS-790052) is a potent direct-acting antiviral agent targeting the HCV NS5A replication complex. Synthesized via advanced organic coupling, its molecular formula is C31H34ClF3N6O4 with CAS 850140-73-7.
Strictly store below 25°C in dry conditions. Clinical use requires monitoring for hepatotoxicity and drug-drug interactions; contraindicated in severe hepatic impairment without specialist supervision.